Patents Examined by Katherine Pebbles
  • Patent number: 10150784
    Abstract: Embodiments of the invention provide solid forms of magnesium glycinate dihydrate and compositions thereof, which are useful for treating hyperphosphatemia and which exhibit desirable characteristics for the same. The invention further provides processes for the production of solid forms of magnesium glycinate dihydrate.
    Type: Grant
    Filed: July 18, 2016
    Date of Patent: December 11, 2018
    Assignee: Cypress Pharmaceuticals, Inc.
    Inventor: Robert L. Lewis